[
  {
    "ts": null,
    "headline": "Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025",
    "summary": "Baron Capitalâs Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and what investors should watch next.",
    "url": "https://finnhub.io/api/news?id=0a3f18f4fd087a83164502be0872194a010302517a4e2dbfb87d9f212ec6b9f0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754603100,
      "headline": "Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025",
      "id": 136263799,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359152753/image_1359152753.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Baron Capitalâs Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and what investors should watch next.",
      "url": "https://finnhub.io/api/news?id=0a3f18f4fd087a83164502be0872194a010302517a4e2dbfb87d9f212ec6b9f0"
    }
  },
  {
    "ts": null,
    "headline": "Oppenheimer Lifts Boston Scientific (BSX) PT to $118 Following Strong Q2 Results",
    "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the most profitable growth stocks to buy according to billionaires. On July 24, Oppenheimer raised its price target for Boston Scientific from $110 to $118, while maintaining a Perform rating on the shares. The adjustment followed the release of the company’s Q2 2025 financial results. In Q2, Boston […]",
    "url": "https://finnhub.io/api/news?id=b4321450526542c57a4cdf4582ce9c195a096d1c312106f9fc99793c165daf77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754584816,
      "headline": "Oppenheimer Lifts Boston Scientific (BSX) PT to $118 Following Strong Q2 Results",
      "id": 136266890,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the most profitable growth stocks to buy according to billionaires. On July 24, Oppenheimer raised its price target for Boston Scientific from $110 to $118, while maintaining a Perform rating on the shares. The adjustment followed the release of the company’s Q2 2025 financial results. In Q2, Boston […]",
      "url": "https://finnhub.io/api/news?id=b4321450526542c57a4cdf4582ce9c195a096d1c312106f9fc99793c165daf77"
    }
  },
  {
    "ts": null,
    "headline": "XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up",
    "summary": "DENTSPLY SIRONA tops Q2 earnings estimates with margin gains, but revenue declines and U.S. weakness persists.",
    "url": "https://finnhub.io/api/news?id=ba6c2ef100ab8f448b72c58141f259626a88e2da141672805afa893d40191393",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754579160,
      "headline": "XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up",
      "id": 136266891,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "DENTSPLY SIRONA tops Q2 earnings estimates with margin gains, but revenue declines and U.S. weakness persists.",
      "url": "https://finnhub.io/api/news?id=ba6c2ef100ab8f448b72c58141f259626a88e2da141672805afa893d40191393"
    }
  },
  {
    "ts": null,
    "headline": "BD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins Up",
    "summary": "BDX tops third-quarter fiscal 2025 earnings and margin estimates, with strong results from its Medical and Interventional segments.",
    "url": "https://finnhub.io/api/news?id=acbc4bbab1115122ff6dcad4d7d791c025a7ffacff04b2aa612c699061601348",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754578920,
      "headline": "BD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins Up",
      "id": 136266892,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BDX tops third-quarter fiscal 2025 earnings and margin estimates, with strong results from its Medical and Interventional segments.",
      "url": "https://finnhub.io/api/news?id=acbc4bbab1115122ff6dcad4d7d791c025a7ffacff04b2aa612c699061601348"
    }
  },
  {
    "ts": null,
    "headline": "ZBH Stock Gains On Q2 Earnings and Revenue Beat, '25 EPS View Up",
    "summary": "Zimmer Biomet gains as Q2 earnings and revenues top estimates; full-year EPS guidance raised on strong segment growth.",
    "url": "https://finnhub.io/api/news?id=418cd27b92399ba251afb87a0c84482e1ff1df9e3c853a29cd40f0b282266828",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754578800,
      "headline": "ZBH Stock Gains On Q2 Earnings and Revenue Beat, '25 EPS View Up",
      "id": 136266893,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Zimmer Biomet gains as Q2 earnings and revenues top estimates; full-year EPS guidance raised on strong segment growth.",
      "url": "https://finnhub.io/api/news?id=418cd27b92399ba251afb87a0c84482e1ff1df9e3c853a29cd40f0b282266828"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific tells users about defibrillator problem linked to deaths, injuries",
    "summary": "A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the leads cannot be assumed or confirmed.",
    "url": "https://finnhub.io/api/news?id=05bd2369c371f71bca647caabe093a08855d70be56e06fa323d4b7ff4d205dde",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754575920,
      "headline": "Boston Scientific tells users about defibrillator problem linked to deaths, injuries",
      "id": 136266894,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the leads cannot be assumed or confirmed.",
      "url": "https://finnhub.io/api/news?id=05bd2369c371f71bca647caabe093a08855d70be56e06fa323d4b7ff4d205dde"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to Know",
    "summary": "Zacks.com users have recently been watching Boston Scientific (BSX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=c1055c13f6bf3e3151efabe2e12a5f5825d748cfaa1dc28c472d24d97a64546a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754571602,
      "headline": "Investors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to Know",
      "id": 136266895,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Boston Scientific (BSX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=c1055c13f6bf3e3151efabe2e12a5f5825d748cfaa1dc28c472d24d97a64546a"
    }
  },
  {
    "ts": null,
    "headline": "MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View",
    "summary": "McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.",
    "url": "https://finnhub.io/api/news?id=a4f67ee382b998426a2b25b5a92c85ab33080f0781a16576caa21cb763c07d21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754569320,
      "headline": "MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View",
      "id": 136266896,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.",
      "url": "https://finnhub.io/api/news?id=a4f67ee382b998426a2b25b5a92c85ab33080f0781a16576caa21cb763c07d21"
    }
  },
  {
    "ts": null,
    "headline": "STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View",
    "summary": "STERIS posts 15% EPS growth and raises FY26 revenue outlook, with all segments showing solid year-over-year gains.",
    "url": "https://finnhub.io/api/news?id=9beb9816ab7928e494b89263fafbbc20c0ec5958763e522bbf170a4df0cd8ce5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754569080,
      "headline": "STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View",
      "id": 136266897,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "STERIS posts 15% EPS growth and raises FY26 revenue outlook, with all segments showing solid year-over-year gains.",
      "url": "https://finnhub.io/api/news?id=9beb9816ab7928e494b89263fafbbc20c0ec5958763e522bbf170a4df0cd8ce5"
    }
  }
]